User profiles for François P. Doz

Francois Doz

Institut Curie
Verified email at curie.fr
Cited by 21406

[HTML][HTML] The transcriptional landscape of Shh medulloblastoma

…, E Bouffet, U Tabori, J Loukides, FP Doz… - Nature …, 2021 - nature.com
Sonic hedgehog medulloblastoma encompasses a clinically and molecularly diverse group
of cancers of the developing central nervous system. Here, we use unbiased sequencing of …

Sonographic, CT, and MR imaging findings in diffuse infiltrative retinoblastoma: report of two cases with histologic comparison

…, PC Fréneaux, P Validire, FP Doz… - American Journal …, 2001 - Am Soc Neuroradiology
Diffuse infiltrating retinoblastoma is a rare form of retinoblastoma. We report two cases of this
disease in which sonographic, CT, and MR imaging findings were compared with histologic …

Activity of larotrectinib in TRK fusion cancer patients with brain metastases or primary central nervous system tumors.

…, N Ku, MC Cox, S Nanda, BH Childs, FP Doz - 2019 - ascopubs.org
2006 Background: TRK fusions are oncogenic drivers of a variety of cancers, many of which
can involve the central nervous system (CNS). Larotrectinib is an FDA-approved selective …

Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.

…, CM van Tilburg, DSW Tan, S Kummar, JJ Lin, FP Doz… - 2021 - ascopubs.org
3108 Background: Neurotrophic tyrosine receptor kinase (NTRK) gene fusions encode
tropomyosin receptor kinase (TRK) fusion proteins, which are oncogenic drivers in various tumor …

[HTML][HTML] Retinoblastoma

…, M Gauthier-Villars, H Brisse, F Doz… - Orphanet journal of rare …, 2006 - Springer
Retinoblastoma is a rare eye tumor of childhood that arises in the retina. It is the most
common intraocular malignancy of infancy and childhood; with an incidence of 1/15,000–20,000 …

Efficacy and safety of larotrectinib in adult and pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system tumors.

…, L Dima, EA De La Cuesta, AE Drilon, FP Doz - 2021 - ascopubs.org
2002 Background: Neurotrophic tyrosine receptor kinase (NTRK) gene fusions are
oncogenic drivers in various tumor types, including central nervous system (CNS) tumors. …

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

…, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz… - Acta …, 2016 - Springer
Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological
variables pertaining to age, presence of metastases, extent of resection, histological …

Photodynamic efficiency of diethylene glycol-linked glycoconjugated porphyrins in human retinoblastoma cells

…, JC Blais, F Doz, B Loock, P Maillard… - Journal of medicinal …, 2006 - ACS Publications
Photodynamic therapy (PDT) is emerging as a new strategy for the conservative treatment of
hereditary retinoblastoma. The glycoconjugated porphyrins TPP(p-Deg-O-α-GalOH) 3 , TPP(…

Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution

…, P Vielh, JL Dufier, JM Zucker, F Doz - … Journal of the …, 1996 - Wiley Online Library
BACKGROUND Microscopic extrascleral involvement and involvement of optic nerve resection
line are accepted risk factors for orbital and/or metastatic disease from retinoblastoma. …

Neonatal cancer

…, M Zerah, E Seigneur, M Peuchmaur, F Doz - The Lancet …, 2013 - thelancet.com
… Prof François Doz, MD François Doz … Correspondence to: Prof François Doz, Department
of Paediatric Oncology, Institut Curie–Hopital, 26 Rue d'Ulm, 75248 Paris Cedex, France …